Longitudinal evaluation of serum leptin and bone mineral density in early postmenopausal women

Menopause

Volumn 14, Issue 3, 2007, Pages 450-454

  Di Carlo, Costantino ^a   Tommaselli, Giovanni A ^a   Di Spiezio Sardo, Attilio ^a   Sammartino, Annalidia ^a   Attianese, Wanda ^a   Gargano, Virginia ^a   Bifulco, Giuseppe ^a   Nappi, Carmine ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Bone mineral density; Dual energy x ray absorptiometry; Estrogen progestin therapy; Leptin; Menopause

Indexed keywords

BONE DENSITY CONSERVATION AGENT; DRUG DERIVATIVE; ESTRADIOL; LEPTIN; MEGESTROL; NOMEGESTROL;

ARTICLE; BLOOD; BONE DENSITY; CALCIUM INTAKE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; ESTROGEN THERAPY; FEMALE; FOLLOW UP; HUMAN; METABOLISM; MIDDLE AGED; POSTMENOPAUSE; RADIODENSITOMETRY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; CALCIUM, DIETARY; DENSITOMETRY, X-RAY; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEPTIN; MEGESTROL; MIDDLE AGED; POSTMENOPAUSE; TREATMENT OUTCOME;

EID: 34447293999     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/01.gme.0000236936.28454.6a     Document Type: Article

References (41)

1. Zhang F, Basinski MB, Beals JM, et al. Crystal structure of the obese protein leptin-E100. Nature 1997;387:206-209.
2. Buyse M, Viengchareun S, Bado A, Lombes M. Insulin and glucocorticoids differentially regulate leptin transcription and secretion in brown adipocytes. FASEB J 2001;15:1357-1366.
3. Laharrague P, Truel N, Fontanilles AM, Corberand JX, Penicaud L, Casteilla L. Regulation by cytokines of leptin expression in human bone marrow adipocytes. Horm Metab Res 2000;32:381-385.
4. Brann DW, De Sevilla L, Zamorano PL, Mahesh VB. Regulation of leptin gene expression and secretion by steroid hormones. Steroids 1999;64:659-663.
5. Yoneda N, Saito S, Kimura M, et al. The influence of ovariectomy on ob gene expression in rats. Horm Metab Res 1998;30:263-265.
6. Shimizu H, Shimomura Y, Nakanishi Y, et al. Estrogen increases in vivo leptin production in rats and human subjects. J Endocrinol 1997;154:285-292.
7. Pinilla L, Seoane M, Gonzalez L, et al. Regulation of serum leptin levels by gonadal function in rats. Eur J Endocrinol 1999;140:468-473.
8. Chu SC, Chou YC, Liu JY, Chen CH, Shyu JC, Chou FP. Fluctuation of serum leptin level in rats after ovariectomy and the influence of estrogen supplement. Life Sci 1999;64:2299-2306.
9. Meli R, Pacilio M, Raso GM, et al. Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose tissue from ovariectomized rats. Endocrinology 2004;145:3115-3121.
10. Hadji P, Hars O, Bock K, et al. The influence of menopause and body mass index on serum leptin concentrations. Eur J Endocrinol 2000;143:55-60.
11. Cento RM, Proto C, Spada RS, et al. Leptin levels in menopause: effect of estrogen replacement therapy. Horm Res 1999;52:269-273.
12. Milewicz A, Bidzinska B, Mikulski E, Demissie U. Influence of obesity and menopausal status on serum leptin, cholecystokinin, galanin and neuropeptide Y levels. Gynecol Endocrinol 2000;14:196-203.
13. Isidori AM, Strollo F, Morè M, et al. Leptin and aging: correlation with endocrine changes in male and female healthy adult populations of different body weights. J Clin Endocrinol Metab 2000;85:1954-1962.
14. Rosenbaum M, Nicolson M, Hirsch J, et al. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 1996;81:3424-3427.
15. Baranowska B, Radzikowska M, Wasilewska-Dziubinska E, Roguski K, Polonowski A. Relationship among leptin, neuropeptide Y, and galanin in young women and in postmenopausal women. Menopause 2000;7:149-155.
16. Di Carlo C, Tommaselli GA, Pisano G. Serum leptin levels in postmenopausal women: effects of transdermal hormone replacement therapy. Menopause 2000;7:36-41.
17. Di Carlo C, Tommaselli GA, Sammartino A, Bifulco G, Nasti A, Nappi C. Serum leptin levels and body composition in postmenopausal women: effects of hormone therapy. Menopause 2004;11:466-473.
18. Ducy P, Amling M, Takeda S, et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000;100:197-207.
19. Thomas T. Leptin: a potential mediator for protective effects of fat mass on bone tissue. Joint Bone Spine 2003;70:18-21.
20. Blain H, Vuillemin A, Guillemin F, et al. Serum leptin level is a predictor of bone mineral density in postmenopausal women. J Clin Endocrinol Metab 2002;87:1030-1035.
21. Pasco JA, Henry MJ, Kotowicz MA, et al. Serum leptin levels are associated with bone mass in nonobese women. J Clin Endocrinol Metab 2001;86:1884-1887.
22. Yamauchi M, Sugimoto T, Yamaguchi T, et al. Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women. Clin Endocrinol 2001;55:341-347.
23. Iwamoto I, Douchi T, Kosha S, Murakami M, Fujino T, Nagata Y. Relationships between serum leptin level and regional bone mineral density, bone metabolic markers in healthy women. Acta Obstet Gynecol Scand 2000;79:1060-1064.
24. Goulding A, Taylor RW. Plasma leptin values in relation to bone mass and density and to dynamic biochemical markers of bone resorption and formation in postmenopausal women. Calcif Tissue Int 1998;63:456-458.
25. Rauch F, Blum WF, Klein K, Allolio B, Schonau E. Does leptin have an effect on bone in adult women? Calcif Tissue Int 1998;63:453-455.
26. Craig CL, Marshall AL, Sjostrom M, et al. International Physical Activity Questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003;35:1381-1395.
27. Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L. A databased approach to diet questionnaire design and testing. Am J Epidemiol 1986;124:453-469.
28. Tremollieres F, Pouilles JM, Ribot C. Postmenopausal bone loss. Role of estrogens. Presse Med 1992;21:903-906.
29. Guthrie JR, Ebeling PR, Hopper JL, et al. A prospective study of bone loss in menopausal Australian-born women. Osteoporos Int 1998;8:282-290.
30. Robinson JA, Harris SA, Riggs BL, Spelsberg TC. Estrogen regulation of human osteoblastic cell proliferation and differentiation. Endocrinology 1997;138:2919-2927.
31. Horowitz M. Cytokines and estrogen in bone: anti-osteoporotic effects. Science 1993;260:626-627.
32. The Writing Group for the PEPI Trial. Effects of hormone therapy on bone mineral density. Results from the Post-menopausal Estrogen/Progesterone Intervention (PEPI) trial. JAMA 1996;276:1389-1396.
33. Cauley JA, Robbins J, Chen Z, et al. Women's Health Initiative Investigators. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA 2003;290:1729-1738.
34. Stevenson JC. Justification for the use of HRT in the long-term prevention of osteoporosis. Maturitas 2005;51:113-126.
35. Haffner SM, Mykkanen L, Stern MP. Leptin concentrations in the San Antonio Heart Study: effect of menopausal status and postmenopausal hormone replacement therapy. Am J Epidemiol 1997;146:581-585.
36. Riondino G, Isidori AM, Fabbri A, et al. Leptin changes in normal weight and obese women in pre- and post-menopausal conditions. J Endocrinol Invest 1999;22:66-67.
37. Gower BA, Nagy TR, Goran MI, Smith A, Kent E. Leptin in postmenopausal women: influence of hormone therapy, insulin, and fat distribution. J Clin Endocrinol Metab 2000;85:1770-1775.
38. Thomas T, Burguera B, Melton LJ III. Role of serum leptin, insulin, and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus women. Bone 2001;29:114-120.
39. Nagy T, Bower G, Trowbridge C, Dezenberg C, Shewchuck RM, Goran MI. Effects of gender, ethnicity, body composition, and fat distribution on serum leptin levels in children. J Clin Endocrinol Metab 1997;82:2148-2152.
40. Hadji P, Bock K, Gotschalk M, et al. The influence of serum leptin concentration on bone mass assessed by quantitative ultrasonometry in pre and postmenopausal women. Maturitas 2003;44:141-148.
41. Di Carlo C, Tommaselli GA, Gargano V, et al. Effects of estrogen-progestin therapy on serum levels of RANKL, osteoprotegerin, osteocalcin, leptin, and ghrelin in postmenopausal women. Menopause 2007;14:38-44.